| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 6664 | 2020 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 792 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 447 | 2022 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 268 | 2022 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 GBDAYAC Collaborators The Lancet Oncology 23 (1), 27-52, 2022 | 134 | 2022 |
| Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy JN Johnson, C Grifoni, JM Bos, M Saber-Ayad, SR Ommen, S Nistri, ... European heart journal 32 (9), 1114-1120, 2011 | 124 | 2011 |
| Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 E Cousin, BB Duncan, C Stein, KL Ong, T Vos, C Abbafati, ... The Lancet diabetes & endocrinology 10 (3), 177-192, 2022 | 86 | 2022 |
| Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells RA El-Awady, MH Semreen, MM Saber-Ayad, F Cyprian, V Menon, ... DNA repair 37, 1-11, 2016 | 75 | 2016 |
| Histone modification in NSCLC: molecular mechanisms and therapeutic targets K Bajbouj, A Al-Ali, RK Ramakrishnan, M Saber-Ayad, Q Hamid International journal of molecular sciences 22 (21), 11701, 2021 | 69 | 2021 |
| Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program HS Kassem, RS Azer, MS Ayad, S Moharem-Elgamal, G Magdy, ... Journal of cardiovascular translational research 6, 65-80, 2013 | 67 | 2013 |
| The rationale for potential pharmacotherapy of COVID-19 M Saber-Ayad, MA Saleh, E Abu-Gharbieh Pharmaceuticals 13 (5), 96, 2020 | 66 | 2020 |
| DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis AJ Laham, M Saber-Ayad, R El-Awady Cellular and Molecular Life Sciences 78, 603-619, 2021 | 52 | 2021 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 51 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 50 | 2024 |
| Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations WM Abdel-Rahman, NA Al-Khayyal, VA Nair, SR Aravind, M Saber-Ayad World journal of gastroenterology 23 (19), 3440, 2017 | 36 | 2017 |
| A mixed methods approach to determine the climate of interprofessional education among medical and health sciences students N Sulaiman, Y Rishmawy, A Hussein, M Saber-Ayad, H Alzubaidi, ... BMC medical education 21, 1-13, 2021 | 34 | 2021 |
| The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells F Alam, F Mezhal, H El Hasasna, VA Nair, SR Aravind, M Saber Ayad, ... Tumor Biology 39 (9), 1010428317714634, 2017 | 34 | 2017 |
| Antibiotic misuse in different hospital wards (a pilot study in an Egyptian hospital) OM Ibrahim, M Saber-Ayad Asian J Pharm Clin Res 5 (2), 95-7, 2012 | 29 | 2012 |
| Complement system: an immunotherapy target in colorectal cancer IM Talaat, NM Elemam, M Saber-Ayad Frontiers in Immunology 13, 810993, 2022 | 28 | 2022 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 26 | 2024 |
iacopo olivottoCardiomyopathy Unit, Careggi University Hospital, Florenceبريد إلكتروني تم التحقق منه على aou-careggi.toscana.it
